Systemic bioactivity of intranasal triamcinolone and mometasone in perennial allergic rhinitis

AIMS: To evaluate the systemic bioactivity of triamcinolone acetonide (TA) 220 µg or mometasone furoate (MF) 200 µg over 3 weeks in perennial allergic rhinitis. METHODS: Twenty-seven patients received TA 220 µg or MF 200 µg once daily for 3 weeks with a 2 week placebo washout period prior to each ra...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Lee, Daniel K C, Robb, Fiona M, Sims, Erika J, Currie, Graeme P, McFarlane, Lesley C, Lipworth, Brian J
Formato: Artigo
Idioma:Inglês
Publicado: Blackwell Science Inc 2003
Assuntos:
Short Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1884214/
https://ncbi.nlm.nih.gov/pubmed/12630983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.2003.01729.x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares